Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay

Cell

Volumn 94, Issue 3, 1998, Pages 353-362

  Kim, J ^a   Yu, W ^a   Kovalski, K ^a   Ossowski, L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GELATINASE B; MATRIX METALLOPROTEINASE; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL ADHESION; CELL GROWTH; DNA SEQUENCE; ENDOTHELIUM CELL; ENZYME ASSAY; HUMAN; HUMAN CELL; METASTASIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032493871     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81478-6     Document Type: Article

References (31)

1. Armstrong, P.B., Quigley, J.P., and Sidebottom, E. (1982). Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res. 42, 1826-1837.
2. Axelrod, J.H., Reich, R., and Miskin, R. (1989). Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol. Cell Biol. 9, 2133-2141.
3. Chambers, A.F., and Matrisian, L.M. (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270.
4. Davies, B., Brown, P.D., East, N., Crimmin, M.J., and Balkwill, F.R. (1993). A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53, 2087-2091.
5. Eccles, S.A., Box, G.M., Court, W.J., Bone, E.A., Thomas, W., and Brown, P.D. (1996). Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res. 56 2815-2822.
6. Foltz, C.M., Rusoo, R.G., Siegal, G.P., Terranova, V.P., and Liotta, L.A. (1982). Interaction of tumor cells with whole basement membrane in the presence or absence of endothelium. In Interaction of Platelets and Tumor Cells, G.A. Jamieson, ed. (New York: Alan R. Liss, Inc.), pp. 353-371.
7. Hearing, V.J., Law, L.W., Corti, A., Apella, E., and Blasi, F. (1988). Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res. 48, 1270-1278.
8. Hua, J., and Muschel, R. (1996). Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in rat sarcoma model system. Cancer Res. 56, 5279-5284.
9. Jaffe, E.A. (1984). Culture and identification of large vessel endothelial cells. In Biology of Endothelial Cells, E.A. Jaffe, ed. (Boston: Martinus Nijhoff Publishers, Kluwer Academic Publishers Group), pp. 1-13.
10. Kariya, Y., Kato, K., Hayashizaki, Y., Himeno, S., Tarui, S., and Matsubura, K. (1987). Revision of concensus sequence of human Alu repeats - a review. Gene 53, 1-10.
11. Kobayashi, H., Gotoh, J., Shinohara, H., Moniwa, N., and Terao, T. (1994). Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model. Thromb. Haemost. 71, 474-480.
12. Koop, S., Schmidt, E.E., MacDonald, I.C., Morris, V.L., Khokha, R., Grattan, M., Leone, J., Chambers, A.F., and Groom, A.C. (1996). Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc. Natl. Acad. Sci. USA 93, 11080-11084.
13. Lengyel, E., Gum, R., Juarez, J., Clayman, G., Seiki, M., Sato, H., and Boyd, D. (1995). Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res. 55, 963-967.
14. Matsumoto, K., Horikashi, M., Rikimaru, K., and Enomoto, S. (1989). A study of an in vitro model for invasion of oral squamous cell carcinoma. J. Oral Pathol. Med. 18, 498-501.
15. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. (1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16, 2319-2332.
16. Mignatti, P., and Rifkin, D.B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-194.
17. Mira y Lopez, R., and Ossowski, L. (1987). Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness. Cancer Res. 47, 3558-3564.
18. Noguchi-Takino, M., Endo, Y., Yonemura, Y., and Sasaki, T. (1996). Relationship between expression of plasminogen activator system and metastatic ability in human cancers. Int. J. Oncol. 8, 97-105.
19. Ossowski, L. (1988a). In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of surface-bound urokinase. J. Cell Biol. 107, 2437-2445.
20. Ossowski, L. (1988b). Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52, 321-328.
21. Ossowski, L. (1992). Invasion for connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res. 52, 6754-6760.
22. Ossowski, L., and Reich, E. (1980). Experimental model for quantitative study of metastasis. Cancer Res. 40, 2300-2309.
23. Ossowski, L., and Reich, E. (1983a). Changes in malignant phenotype of human carcinoma conditioned by growth environment. Cell 33, 323-333.
24. Ossowski, L., and Reich, E. (1983b). Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35, 611-619.
25. Poste, G., Doll, J., Hart, I.R., and Fidler, I.J. (1980). In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 40, 1636-1644.
26. Rizzo, V., Steifeld, R., Kyriakides, C., and DeFouw, D.O. (1993). The microvasculature unit of the 6-day chick chorioallantoic membrane: afluorescent confocal microscopy and ultrastructural morphometric analysis of endothelial permselectivity. Microvasc. Res. 46, 320-332.
27. Shioda, T., Munn, L.L., Fenner, M.H., Jain, R.K., and Isselbacher, K.J. (1997). Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells. Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane. Am. J. Pathol. 150, 2099-2112.
28. Sundareshan, P., Kostler, J.J., Nagle, R.B., and Bowden, G.T. (1997). Coordinated expression of matrilysin during TPA-induced apoptosis of LNCaP cells: two parallel processes affected by TPA. Cancer Lett. 113, 17-24.
29. Yu, H., and Schultz, R.M. (1990). Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B 16 cells transfected with human urokinase sense and antisense genes. Cancer Res. 50, 7623-7633.
30. Yu, W., Kim, J., and Ossowski, L. (1997). Reduction in surface urokinase receptor forces malignant cells into protracted state of dormancy. J. Cell Biol. 137, 767-777.
31. Zubair, A.C., Ali, S.A., Rees, B.C., Goepe, J.R., and Goyns, M.H. (1996). Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice. Cancer Lett. 107, 91-95.